Genpact Limited (NYSE:G – Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 5,090,000 shares, a decrease of 7.6% from the December 15th total of 5,510,000 shares. Approximately 3.2% of the company’s stock are short sold. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is currently 3.9 days.
Genpact Stock Performance
Genpact stock traded up $0.29 on Monday, reaching $45.13. 956,882 shares of the stock were exchanged, compared to its average volume of 1,135,612. The stock has a market cap of $7.96 billion, a PE ratio of 12.40, a PEG ratio of 1.43 and a beta of 1.18. The firm has a fifty day moving average price of $44.44 and a two-hundred day moving average price of $39.78. Genpact has a twelve month low of $30.23 and a twelve month high of $47.98. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. Needham & Company LLC increased their price objective on Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, November 11th. TD Cowen raised their price target on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a report on Friday, November 8th. Finally, Robert W. Baird upped their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Eight research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Genpact presently has an average rating of “Hold” and a consensus target price of $42.33.
Insider Activity
In other news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Friday, December 13th. The stock was sold at an average price of $44.60, for a total value of $606,560.00. Following the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 35,058 shares of company stock worth $1,558,675 in the last 90 days. Company insiders own 2.80% of the company’s stock.
Institutional Trading of Genpact
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in G. UMB Bank n.a. grew its position in Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after purchasing an additional 433 shares during the last quarter. Venturi Wealth Management LLC grew its position in Genpact by 74.6% during the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock worth $103,000 after buying an additional 1,121 shares in the last quarter. Versant Capital Management Inc increased its stake in Genpact by 17.0% during the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock valued at $136,000 after acquiring an additional 461 shares during the period. GAMMA Investing LLC raised its holdings in Genpact by 221.3% in the 3rd quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock valued at $131,000 after acquiring an additional 2,293 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in Genpact by 22.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider’s stock valued at $145,000 after acquiring an additional 619 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- How to Use the MarketBeat Stock Screener
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.